Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-20.55 Insider Own0.10% Shs Outstand145.84M Perf Week-4.31%
Market Cap12.40B Forward P/E16.68 EPS next Y5.10 Insider Trans-4.68% Shs Float141.89M Perf Month8.19%
Income-2947.30M PEG- EPS next Q1.11 Inst Own86.70% Short Float9.72% Perf Quarter13.92%
Sales5.02B P/S2.47 EPS this Y-9.70% Inst Trans6.67% Short Ratio8.66 Perf Half Y24.77%
Book/sh42.44 P/B2.00 EPS next Y11.23% ROA-21.20% Target Price81.63 Perf Year-9.23%
Cash/sh- P/C- EPS next 5Y7.80% ROE-46.10% 52W Range63.68 - 99.14 Perf YTD2.17%
Dividend0.64 P/FCF21.47 EPS past 5Y-54.10% ROI-9.90% 52W High-14.22% Beta0.68
Dividend %0.75% Quick Ratio1.20 Sales past 5Y10.70% Gross Margin38.60% 52W Low33.54% ATR1.93
Employees12800 Current Ratio1.70 Sales Q/Q-7.70% Oper. Margin-36.10% RSI (14)59.48 Volatility2.24% 2.23%
OptionableYes Debt/Eq0.60 EPS Q/Q87.00% Profit Margin-58.70% Rel Volume0.61 Prev Close85.48
ShortableYes LT Debt/Eq0.54 EarningsAug 10 BMO Payout- Avg Volume1.59M Price85.04
Recom2.70 SMA203.62% SMA509.90% SMA20012.41% Volume964,477 Change-0.51%
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Sep-21-17 09:29AM  Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets PR Newswire
08:05AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Sep-20-17 08:05AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Sep-19-17 06:00AM  Jeffery Smith's best idea CNBC Videos
Sep-18-17 08:59AM  Perrigo says the FDA has given tentative approval to generic acne gel MarketWatch
08:45AM  Perrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel PR Newswire
08:05AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Sep-14-17 08:06AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Sep-13-17 07:53PM  ETFs with exposure to Perrigo Co. Plc : September 13, 2017 Capital Cube
11:29AM  Perrigo's Stock Up, Starboard's CEO Calls it a Key Pick Zacks
03:00AM  Perrigo Scores Relative Strength Rating Upgrade; Hits Key Threshold Investor's Business Daily
Sep-12-17 01:44PM  Perrigo Stock Jumps as Starboard's Smith Says Generic Drugs a Strong Business TheStreet.com
12:00PM  Perrigo surges as Starboard Value's Jeff Smith talks up the stock MarketWatch
11:55AM  Starboard Value says Amazon sales a boon for Perrigo Reuters
11:47AM  Starboard Value CEO Smith pushes Perrigo, Altaba as best ideas CNBC
11:44AM  Starboard Value CEO Jeff Smith: Perrigo and Altaba are ou... CNBC Videos
11:30AM  Starboard Value CEO Smith: Our best investment idea is Pe... CNBC Videos
09:14AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is STILL Too Ugly to Buy InvestorPlace
Sep-11-17 12:47PM  Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017 Capital Cube
10:11AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Sep-08-17 01:17PM  Feds want to deny Martin Shkreli bail Yahoo Finance Video
10:27AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Sep-07-17 04:37PM  Evening Sector Snapshot: Pharmaceuticals Climb, Disney Falls Barrons.com
Aug-30-17 09:01AM  Perrigo Company To Present At Upcoming Investor Conferences PR Newswire
Aug-25-17 12:35PM  Is the Valeant Pharmaceuticals Intl Inc (VRX) Debt Situation Overblown? InvestorPlace
Aug-23-17 01:38PM  SAC Capital's Martoma fails to overturn U.S. insider trading conviction Reuters
Aug-22-17 06:05PM  Perrigo's (PRGO) OTC Version of Nexium Secures FDA Approval Zacks
Aug-21-17 09:00AM  Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules PR Newswire
07:10AM  Earnings Review and Free Research Report: Perrigo Reported Better than Expected Revenue and Earnings Results ACCESSWIRE
Aug-16-17 08:51AM  Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog® II Cream PR Newswire
Aug-14-17 04:12PM  Perrigo: Still A Hard Pill To Swallow Barrons.com
12:06PM  Edited Transcript of PRGO earnings conference call or presentation 10-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
11:49AM  The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant Zacks
Aug-12-17 08:06AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Aug-11-17 10:27AM  Perrigo is the rare generic drugmaker that isnt suffering right now MarketWatch
09:58AM  Company News For August 11, 2017 Zacks
08:07AM  Perrigo upgraded to neutral by Goldman MarketWatch
07:05AM  Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure Zacks
Aug-10-17 08:02PM  Perrigo reports 2Q loss Associated Press +15.78%
06:15PM  Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions TheStreet.com
04:34PM  The Hot Stock: Perrigo Soars 16% Barrons.com
04:29PM  Why Pan American Silver, Chefs' Warehouse, and Perrigo Jumped Today Motley Fool
04:14PM  Perrigo (PRGO) Q2 Earnings & Sales Top, 2017 View Raised Zacks
12:51PM  Kohl's, Dillard's, Live Nation Entertainment Moving Despite International Tensions GuruFocus.com
12:31PM  [$$] SK Capital to Buy Perrigo's Active Pharmaceutical Ingredients Business The Wall Street Journal
12:18PM  Here's Why Perrigo Company Rose as Much as 20.5% Today Motley Fool
11:22AM  Why Perrigo is Soaring Barrons.com
10:01AM  These Biotech Stocks are BOOMING TheStreet.com
08:58AM  Perrigo Co. shares surge 12% after Q2 profit, revenue beats MarketWatch
08:23AM  Morning Movers: Macy's, Perrigo Gain on Earnings; Dillard's, Chicago Bridge Tumble Barrons.com
08:05AM  IHS Markit Score Update: Drop in demand for ETFs holding Perrigo Company PLC is a negative sign for its shares Markit
07:43AM  Early movers: KSS, APRN, GOOS, PRGO, EAT, DAL, FOXA, JACK, ELF & more CNBC
07:37AM  US STOCKS-Futures lower as N.Korea tensions extend to third day Reuters
02:02AM  Perrigo Company plc Reports Second Quarter 2017 Financial Results PR Newswire
Aug-08-17 10:51AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
09:38AM  Endo's U.S. generics business beats estimates Reuters
Aug-07-17 11:27PM  Perrigo Company (PRGO) Q2 Earnings: What's in the Cards? Zacks
Aug-04-17 09:20AM  Perrigo Announces Tentative FDA Approval For Generic Version Of Mirvaso® Gel PR Newswire
Aug-03-17 09:53AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : August 3, 2017 Capital Cube -5.30%
Aug-01-17 07:20PM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : August 1, 2017 Capital Cube
Jul-31-17 09:20AM  Perrigo Announces The Launch Of The AB Rated Generic Version Of Transderm Scop® 1.5 mg PR Newswire
Jul-27-17 04:47PM  Perrigo To Release Second Quarter 2017 Financial Results On August 10, 2017 PR Newswire
Jul-24-17 06:17PM  ETFs with exposure to Perrigo Co. Plc : July 24, 2017 Capital Cube
12:30PM  Should You Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons InvestorPlace
Jul-19-17 09:13AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : July 19, 2017 Capital Cube
08:57AM  Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of DermOtic® Oil, 0.01% Ear Drops PR Newswire
Jul-18-17 06:12PM  Perrigo Company Gets FDA Approval for Generic Topical Gel Zacks
Jul-17-17 09:08AM  Perrigo Confirms Patent Challenge For Generic Version Of Soolantra® Cream, 1% PR Newswire
09:07AM  Perrigo Announces FDA Final Approval For Its First-To-File Ab Rated Generic Version Of Androgel® Topical Gel, 1.62% Packets PR Newswire
09:06AM  Perrigo Announces Settlement Of Generic Version Of Dymista® Nasal Spray Patent Litigation PR Newswire
Jul-14-17 04:21PM  ETFs with exposure to Perrigo Co. Plc : July 14, 2017 Capital Cube
Jul-10-17 04:11PM  The Royalty-Amassing Strategy Of Royalty Pharma Benzinga
Jul-08-17 08:48AM  Activists Forced CEOs to Leave These Huge Companies This Year TheStreet.com
Jul-07-17 09:44AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : July 7, 2017 Capital Cube
Jul-06-17 09:12AM  [$$] The Angst of Endangered CEOs: 'How Much Time Do I Have?' The Wall Street Journal
12:06AM  [$$] The Angst of Endangered CEOs: How Much Time Do I Have? The Wall Street Journal
Jul-05-17 09:00AM  Perrigo Launches The Generic Version Of Axiron® Topical Solution PR Newswire
Jun-30-17 04:01AM  Why Is Perrigo (PRGO) Up 5% Since the Last Earnings Report? Zacks
Jun-29-17 01:29PM  Perrigo Finance Unlimited Company -- Moody's affirms Perrigo's Baa3 rating; revises outlook to stable Moody's
Jun-28-17 08:18AM  Here are the winners and losers in the health-care sector CNBC Videos
Jun-22-17 12:22PM  Health-Care Stocks Get a Boost From Senate Bill Rollout The Wall Street Journal
Jun-21-17 09:50AM  Perrigo Company Retains Spencer Stuart for CEO Search PR Newswire
08:32AM  Perrigo Announces the Launch of Generic Equivalents to Derma-Smoothe/FS® Scalp Oil and Body Oil PR Newswire
Jun-20-17 09:07AM  Dupixent May Be a Major Growth Driver for Regeneron in 2017 Market Realist
08:15AM  Earnings Highlights and Review: Perrigo Reported Better-than-Expected Quarterly Results Accesswire
Jun-19-17 09:13AM  Perrigo Announces the Launch of Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution PR Newswire
Jun-16-17 10:54AM  Valeant: Stop Looking in the Rearview Mirror! Barrons.com
Jun-15-17 03:02PM  ETFs with exposure to Perrigo Co. Plc : June 15, 2017 Capital Cube
Jun-14-17 01:38PM  Perrigo Company plc Announces Pricing for its Cash Tender Offer PR Newswire
09:25AM  Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
09:12AM  Perrigo Company To Present At The 17th Annual Oppenheimer Consumer Conference PR Newswire
07:30AM  Perrigo Company plc Announces Early Tender Results for Cash Tender Offer PR Newswire
Jun-13-17 12:07PM  Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space TheStreet.com
Jun-09-17 08:37AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : June 9, 2017 Capital Cube
Jun-08-17 01:00AM  Small is lucrative for Wachtell, corporate America's legal defense force Reuters
Jun-06-17 12:16PM  Perrigo: As the Revolving Door Spins Barrons.com
07:29AM  US STOCKS-Futures slip as investors turn risk averse Reuters
06:42AM  DISH to pay $280M in telemarking lawsuit CNBC Videos
12:28AM  [$$] Perrigo CEO to Leave After 14 Months The Wall Street Journal
12:11AM  PRESS DIGEST - Wall Street Journal - June 6 Reuters
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. The company also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services; and generic pharmaceutical products. The company offers its products through retail drug, supermarket, mass merchandise chains, wholesalers, pharmacies, drug and grocery stores, para pharmacies, and hospitals, as well as through a network of pharmacy sales force and pharmacists in North America, Europe, Australia, Israel, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Janish Ronald CraigEVP, Global Op. & Supply ChainSep 12Sale88.7126123,1541,616Sep 14 07:18 PM
Needham JeffreyEVP, President CHC AmericasSep 12Sale89.493,595321,7079,718Sep 14 07:13 PM
Kochan SharonEVP, GM InternationalSep 07Sale81.3631825,87410,031Sep 11 04:56 PM
Kochan SharonEVP, GM InternationalAug 31Sale79.031,500118,54510,349Sep 05 02:33 PM
Farrington ThomasEVP and CIOAug 30Sale76.9061647,3702,724Sep 01 12:13 PM
Winowiecki RonaldInterim CFOAug 21Option Exercise77.5822717,6111,411Aug 23 08:25 PM
HENDRICKSON JOHN TCEOAug 21Option Exercise77.581,316102,0956,211Aug 23 08:23 PM
Weninger PaulEVP, Quality OperationsAug 21Option Exercise77.5816813,0332,337Aug 23 08:21 PM
Quinn GrainneEVP, Chief Medical OfficerAug 21Option Exercise77.5814711,4042,227Aug 23 08:19 PM
Farrington ThomasEVP and CIOAug 21Option Exercise77.5866851,8232,773Aug 23 08:16 PM
KINGMA TODD WExecutive VP, General CounselAug 21Option Exercise77.581,316102,09515,876Aug 23 08:13 PM
Needham JeffreyEVP, President CHC AmericasAug 21Option Exercise77.581,11386,34712,369Aug 23 08:11 PM
Kochan SharonEVP, GM InternationalAug 21Option Exercise77.581,11386,34710,707Aug 23 08:08 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 21Option Exercise77.5825820,0161,732Aug 23 08:04 PM
Wesolowski JohnEVP, President RxAug 21Option Exercise77.5813410,396356Aug 23 07:59 PM
Farrington ThomasEVP and CIOAug 18Sale78.4086567,8122,105Aug 22 05:24 PM
Alford Bradley ADirectorJul 20Option Exercise75.511,01776,7941,017Jul 24 04:56 PM
Parker Geoffrey M.DirectorJul 20Option Exercise75.511,948147,0931,437Jul 24 04:54 PM
Samuels Theodore R. IIDirectorJul 20Option Exercise75.511,359102,6181,359Jul 24 04:49 PM
KINDLER JEFFREY BDirectorJul 20Option Exercise75.511,01776,7941,017Jul 24 04:47 PM
Smith Jeffrey CDirectorJul 20Option Exercise75.511,01776,7941,017Jul 24 04:25 PM
BRLAS LAURIEDirectorJun 21Option Exercise73.3377857,05112,931Jun 22 04:44 PM
Needham JeffreyEVP, President CHC AmericasMay 31Option Exercise72.8551537,51811,419Jun 02 12:40 PM
O'Connor DonalDirectorMay 31Option Exercise72.853,263237,7104,875Jun 02 12:37 PM
BRLAS LAURIEDirectorMay 31Option Exercise72.853,263237,71013,720Jun 02 12:35 PM
COHEN GARY MDirectorMay 31Option Exercise72.853,263237,71016,614Jun 02 12:30 PM
Wesolowski JohnEVP, President RxDec 15Option Exercise82.6132526,848325Dec 19 04:07 PM
Brown Judy LEVP, Business Ops & CFONov 25Sale89.442,097187,55610,007Nov 28 04:29 PM
Parker Geoffrey M.DirectorNov 21Buy88.752,500221,8752,500Nov 21 03:14 PM
KINGMA TODD WExecutive VP, General CounselNov 21Sale88.6875066,51214,560Nov 23 02:30 PM
Brown Judy LEVP, Business Ops & CFOOct 24Sale90.422,092189,15912,104Oct 26 02:44 PM
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM